Project Grant R01HD114744
Award Date
8/1/24
Completion Date
5/31/29
Dollars Obligated
$635K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Galveston, TX 77555, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $248,999 to Vanderbilt University Medical Center (VUMC) to develop novel therapeutic interventions for infection-induced preterm birth. The primary objectives are to 1) optimize a high-throughput screening assay to identify small-molecule compounds that can regulate pro-inflammatory cytokine release...
This federal Project Grant award of $414,026, provided by the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, will support research to determine the mechanism by which maternal interleukin-10 (IL-10) restricts fetal emergency myelopoiesis, with the goal of improving neonatal outcomes. The research, conducted by Childrens Hospital Medical Center in Cincinnati, Ohio, aims to: 1) identify the...
The National Institute of Child Health and Human Development (NICHD) has awarded a $423,985 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Illinois to develop a novel non-invasive monitoring system for detecting placental dysfunction and associated pregnancy complications. The funding will support research to utilize extracellular vesicles (EVs) circulating in maternal blood as biomarkers, using a "target recycling...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the mechanisms by which the cytokine interleukin-9 (IL-9) at the maternal-fetal interface promotes preterm labor and birth, and the impact on offspring. The total award amount is $545,686.00 and the performance period runs from August 17, 2024 to June 30, 2029. The key products and services to be...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports the development of a novel, uterine-targeted drug delivery system to treat preterm labor, a leading cause of neonatal mortality. The $126,568 award to Vanderbilt University will fund research to improve the encapsulation efficiency and antibody targeting of the drug delivery system, as well as evaluate its in vivo...
This federal Project Grant award of $2,060,562 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate the use of a novel synthetic progestin, R5020, for preventing preterm labor and reducing fetal inflammation caused by intrauterine infection and inflammation (IUI). The research, to be conducted by the University of California, Los Angeles (UCLA), focuses on two key...
This Project Grant award, with ID K99HD116981, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $132,779 award supports research to examine the role of TLR7/8-activating microRNAs in driving fetal inflammatory response syndrome associated with preterm birth and chorioamnionitis. The primary objectives are to determine if fetal membranes and amniotic fluid-derived...
This $349,375 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a targeted lipid nanoparticle (LNP) platform for delivering therapeutic mRNA to the placenta as a treatment for pre-eclampsia, a serious pregnancy complication. The key objectives are to: 1) use high-throughput screening to identify LNPs with placental tropism, 2) functionalize lead LNP...
This $717,871 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop epigenomic liquid biopsy methods for early detection and prediction of preterm birth and related pregnancy complications. The grant supports research to: Predict the clinical trajectories of pregnancies affected by preeclampsia and intrauterine growth restriction, and Screen for...
The National Institute of Child Health and Human Development (NICHD) awarded a $424,875 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the University of Maryland, Baltimore (UMB) to investigate the role of placental serum amyloid A (SAA) isoforms in response to sub-chronic maternal inflammation and explore whether inhibition of the SAA2 isoform using small interfering RNA (siRNA) can alleviate preterm birth and adverse fetal outcomes. The project aims...